PAP

Persistent Asset Partners Portfolio holdings

AUM $258M
1-Year Est. Return 159.18%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+159.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$258M
AUM Growth
+$49.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
426
New
Increased
Reduced
Closed

Top Buys

1 +$9.09M
2 +$8.24M
3 +$6.49M
4
INTC icon
Intel
INTC
+$5.94M
5
ALAB icon
Astera Labs
ALAB
+$4.77M

Top Sells

1 +$9.07M
2 +$8.9M
3 +$8.08M
4
BTSG icon
BrightSpring Health Services
BTSG
+$3.52M
5
TERN
Terns Pharmaceuticals
TERN
+$2.78M

Sector Composition

1 Technology 46.48%
2 Healthcare 30.91%
3 Financials 9.41%
4 Consumer Discretionary 4.08%
5 Energy 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADAG
201
Adagene
ADAG
$224M
$138K 0.05%
+35,126
SLSR
202
Solaris Resources
SLSR
$1.84B
$138K 0.05%
15,956
-10,160
NVO
203
Novo Nordisk
NVO
$190B
$135K 0.05%
+3,685
PSNL icon
204
Personalis
PSNL
$1.17B
$133K 0.05%
+20,929
CNTB
205
Connect Biopharma Holdings
CNTB
$135M
$133K 0.05%
50,747
+23,973
ANTX icon
206
AN2 Therapeutics
ANTX
$147M
$130K 0.05%
+38,155
QURE icon
207
uniQure
QURE
$1.69B
$129K 0.05%
7,887
-3,127
PTHS
208
Pelthos Therapeutics
PTHS
$90.4M
$126K 0.05%
6,007
MKSI icon
209
MKS Inc
MKSI
$22.4B
$120K 0.05%
+520
AVTX icon
210
Avalo Therapeutics
AVTX
$734M
$118K 0.05%
7,918
-7,169
MNKD icon
211
MannKind Corp
MNKD
$1.06B
$116K 0.05%
47,394
-34,069
LPCN icon
212
Lipocine
LPCN
$18.5M
$107K 0.04%
13,442
-57,134
URGN icon
213
UroGen Pharma
URGN
$1.29B
$105K 0.04%
5,824
-6,982
SLB icon
214
SLB Ltd
SLB
$84.6B
$103K 0.04%
2,000
-8,000
CORT icon
215
Corcept Therapeutics
CORT
$7.64B
$102K 0.04%
2,528
-23,304
GHRS icon
216
GH Research
GHRS
$1.71B
$95.5K 0.04%
+6,794
ADPT icon
217
Adaptive Biotechnologies
ADPT
$2.42B
$92.8K 0.04%
6,689
OCGN icon
218
Ocugen
OCGN
$454M
$91.5K 0.04%
+50,559
IRD
219
Opus Genetics
IRD
$325M
$81.5K 0.03%
+17,919
PRQR icon
220
ProQR Therapeutics
PRQR
$155M
$74.6K 0.03%
46,067
+913
HUYA
221
Huya Inc
HUYA
$625M
$73.5K 0.03%
22,273
-31,032
IVVD icon
222
Invivyd
IVVD
$336M
$72.8K 0.03%
55,990
-12,853
PEPG icon
223
PepGen
PEPG
$100M
$67.5K 0.03%
+38,152
YSG
224
Yatsen Holding
YSG
$325M
$62.1K 0.02%
20,151
+9,819
PGEN icon
225
Precigen
PGEN
$1.38B
$54.1K 0.02%
+13,978